Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MRTX-1719 is a potent, first-in-class, selective inhibitor of the PRMT5/MTA complex, with an IC50 of less than 10 nM in PRMT5/MTA MTAP DEL SDMA cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 913.00 | |
5 mg | In stock | $ 1,790.00 | |
10 mg | In stock | $ 2,370.00 | |
25 mg | In stock | $ 3,530.00 | |
50 mg | In stock | $ 4,770.00 | |
100 mg | In stock | $ 6,430.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 1,960.00 |
Description | MRTX-1719 is a potent, first-in-class, selective inhibitor of the PRMT5/MTA complex, with an IC50 of less than 10 nM in PRMT5/MTA MTAP DEL SDMA cells. |
Targets&IC50 | PRMT5/MTAMTAPDELSDMA cells:<10 nM (IC50) |
Molecular Weight | 464.88 |
Formula | C23H18ClFN6O2 |
CAS No. | 2630904-45-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (107.55 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MRTX-1719 2630904-45-7 Chromatin/Epigenetic Histone Methyltransferase CRC MRTX 1719 NSCLC Inhibitor MTA MRTX1719 inhibit PRMT5 inhibitor